Source: Eur Respir J, 52 (6) 1801297; 10.1183/13993003.01297-2018
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
David B. Hill, Robert F. Long, William J. Kissner, Eyad Atieh, Ian C. Garbarine, Matthew R. Markovetz, Nicholas C. Fontana, Matthew Christy, Mehdi Habibpour, Robert Tarran, M. Gregory Forest, Richard C. Boucher, Brian Button. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH. Eur Respir J, 52 (6) 1801297; 10.1183/13993003.01297-2018

Member's Comments

No comment yet.

Related content which might interest you: Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis Source: Eur Respir J 2008; 31: 765-772 Year: 2008 Airway surface pH in subjects with cystic fibrosis Source: Eur Respir J 2003; 21: 37-42 Year: 2003 Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 Cyanide levels found in infected cystic fibrosis sputum inhibit airway ciliary function Source: Eur Respir J 2014; 44: 1253-1261 Year: 2014 Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect Source: Eur Respir J 2004; 24: 95-100 Year: 2004 Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Presence of mucus plugging is predictive of long term lung function in children with cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 527s Year: 2002 New concepts of the pathogenesis of cystic fibrosis lung disease Source: Eur Respir J 2004; 23: 146-158 Year: 2004 Association of residual function of cystic fibrosis transmembrane conductance regulator and lung clearance index in patients with normal FEV1 Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children Year: 2017 Cystic fibrosis lung disease: from molecular defect to abnormal mucocilliary clearance Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics Year: 2007 LSC 2010 Abstract: Ceramide is increased and associated with neutrophilic inflammation in the lower airway epithelium of people with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration Source: Eur Respir J, 52 (4) 1800668; 10.1183/13993003.00668-2018 Year: 2018 Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Clinical correlation of epithelial barrier dysfunction related to neutrophilic inflammation in cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006 Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 Year: 2018